Rice expert available to comment on FDA decision on sickle cell disease therapy
October 31, 2023
October 31, 2023
HOUSTON, Texas, Oct. 31 -- Rice University issued the following news release:
The U.S. Food and Drug Administration is about to make history today with its decision on whether or not to approve a CRISPR-based treatment for sickle cell disease, an inherited disorder that distorts the shape of red blood cells and disrupts the function of hemoglobin, the protein that carries and distributes oxygen throughout the body.
Rice University's Gang Bao, a pioneer in nanomedicin . . .
The U.S. Food and Drug Administration is about to make history today with its decision on whether or not to approve a CRISPR-based treatment for sickle cell disease, an inherited disorder that distorts the shape of red blood cells and disrupts the function of hemoglobin, the protein that carries and distributes oxygen throughout the body.
Rice University's Gang Bao, a pioneer in nanomedicin . . .